Market Overview:
The global bioPharma cold chain packaging market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biopharmaceuticals and rising concerns over product safety and security. The metal packaging segment is expected to dominate the global bioPharma cold chain packaging market during the forecast period, owing to its properties such as durability, strength, and resistance against corrosion. By application, blood components are expected to account for the largest share of the global bioPharma cold chain packaging market in 2018. This can be attributed to factors such as growing demand for blood transfusions and rising prevalence of diseases that require blood transfusions.
Product Definition:
BioPharma Cold Chain Packaging is the use of packaging specifically designed to maintain the cold chain for biopharmaceutical products. The importance of BioPharma Cold Chain Packaging is to maintain product quality and safety during transport and storage.
Metal Packaging:
Metal packaging is a cost-effective and environment-friendly solution for the pharmaceutical industry. Metal packaging offers robust, stable, safe and flexible solutions to store drugs. It can be used in various forms such as cans, bottles & jars or blister packs owing to its high thermal efficiency which helps preserve medicines quality during storage at low & ambient temperatures.
The global metal packaging market size was valued at USD 23 billion in 2015.
Glass Packaging:
Glass packaging is a material that is widely used for the packing of pharmaceutical products. It offers several advantages such as inertness, transparency, and low reactivity. The global glass packaging market size was valued at USD 23 billion in 2016 and it is expected to grow at a CAGR of XX% over the forecast period.
Application Insights:
The global bio pharma cold chain packaging market is segmented on the basis of application into blood components, vaccines, tissues and cells, stem cells and infectious substances. The infectious substance segment held the largest share in 2017 owing to stringent government regulations for safe handling of these products.
Blood components emerged as one of the leading applications for bio-packaging solutions across all regions due to rising awareness about transfusion safety among consumers as well as healthcare professionals. Moreover, increasing incidences of blood borne infections such as HIV among others are further anticipated to boost demand over the forecast period.
Stem cell research has gained significant momentum in recent years owing to growing public support.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biopharmaceutical manufacturers, which are majorly focused on developing and commercializing products that require specialized packaging such as vaccines, blood components and tissue culture cells. The region is expected to maintain its dominance over the forecast period owing to factors such as favorable government policies for promoting investments in life science research & development activities and increasing R&D expenditure by companies operating in this sector.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing healthcare spending by countries like China, India and Japan along with other Southeast Asian nations coupled with an increase in investment opportunities offered by public-private partnerships between governments & bio-pharmaceutical industries.
Growth Factors:
- Increasing demand for biopharmaceuticals: The global market for biopharmaceuticals is expected to grow at a CAGR of 10.8% from 2016 to 2021, reaching a value of 2.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising awareness about preventive healthcare, and technological advancements in the field of biotechnology.
- Growing demand for temperature-controlled transportation and storage: The global cold chain logistics market is expected to grow at a CAGR of 9% from 2016 to 2021, reaching a value of 5.9 billion by 2021. This growth can be attributed to the increasing demand for temperature-controlled transportation and storage services across various industries such as food & beverage, pharmaceuticals, medical devices, and cosmetics & personal care products.
Scope Of The Report
Report Attributes
Report Details
Report Title
BioPharma Cold Chain Packaging Market Research Report
By Type
Metal Packaging, Glass Packaging
By Application
Blood Components, Vaccines, Tissues, Cells, Stem Cells, Infectious Substances
By Companies
Amcor, CCL, Clondalkin, Gerresheimer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global BioPharma Cold Chain Packaging Market Report Segments:
The global BioPharma Cold Chain Packaging market is segmented on the basis of:
Types
Metal Packaging, Glass Packaging
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood Components, Vaccines, Tissues, Cells, Stem Cells, Infectious Substances
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amcor
- CCL
- Clondalkin
- Gerresheimer
Highlights of The BioPharma Cold Chain Packaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metal Packaging
- Glass Packaging
- By Application:
- Blood Components
- Vaccines
- Tissues
- Cells
- Stem Cells
- Infectious Substances
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the BioPharma Cold Chain Packaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
BioPharma cold chain packaging is a specialized type of packaging that is designed to protect medications and other biological products from the adverse effects of temperature and humidity. Cold chain packaging can help ensure that medications remain safe and effective during transport, storage, and use.
Some of the major players in the biopharma cold chain packaging market are Amcor, CCL, Clondalkin, Gerresheimer.
The biopharma cold chain packaging market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 BioPharma Cold Chain Packaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 BioPharma Cold Chain Packaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 BioPharma Cold Chain Packaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the BioPharma Cold Chain Packaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global BioPharma Cold Chain Packaging Market Size & Forecast, 2018-2028
4.5.1 BioPharma Cold Chain Packaging Market Size and Y-o-Y Growth
4.5.2 BioPharma Cold Chain Packaging Market Absolute $ Opportunity
Chapter 5 Global BioPharma Cold Chain Packaging Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 BioPharma Cold Chain Packaging Market Size Forecast by Type
5.2.1 Metal Packaging
5.2.2 Glass Packaging
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global BioPharma Cold Chain Packaging Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 BioPharma Cold Chain Packaging Market Size Forecast by Applications
6.2.1 Blood Components
6.2.2 Vaccines
6.2.3 Tissues
6.2.4 Cells
6.2.5 Stem Cells
6.2.6 Infectious Substances
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global BioPharma Cold Chain Packaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 BioPharma Cold Chain Packaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America BioPharma Cold Chain Packaging Analysis and Forecast
9.1 Introduction
9.2 North America BioPharma Cold Chain Packaging Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America BioPharma Cold Chain Packaging Market Size Forecast by Type
9.6.1 Metal Packaging
9.6.2 Glass Packaging
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America BioPharma Cold Chain Packaging Market Size Forecast by Applications
9.10.1 Blood Components
9.10.2 Vaccines
9.10.3 Tissues
9.10.4 Cells
9.10.5 Stem Cells
9.10.6 Infectious Substances
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe BioPharma Cold Chain Packaging Analysis and Forecast
10.1 Introduction
10.2 Europe BioPharma Cold Chain Packaging Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe BioPharma Cold Chain Packaging Market Size Forecast by Type
10.6.1 Metal Packaging
10.6.2 Glass Packaging
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe BioPharma Cold Chain Packaging Market Size Forecast by Applications
10.10.1 Blood Components
10.10.2 Vaccines
10.10.3 Tissues
10.10.4 Cells
10.10.5 Stem Cells
10.10.6 Infectious Substances
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific BioPharma Cold Chain Packaging Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific BioPharma Cold Chain Packaging Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific BioPharma Cold Chain Packaging Market Size Forecast by Type
11.6.1 Metal Packaging
11.6.2 Glass Packaging
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific BioPharma Cold Chain Packaging Market Size Forecast by Applications
11.10.1 Blood Components
11.10.2 Vaccines
11.10.3 Tissues
11.10.4 Cells
11.10.5 Stem Cells
11.10.6 Infectious Substances
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America BioPharma Cold Chain Packaging Analysis and Forecast
12.1 Introduction
12.2 Latin America BioPharma Cold Chain Packaging Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America BioPharma Cold Chain Packaging Market Size Forecast by Type
12.6.1 Metal Packaging
12.6.2 Glass Packaging
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America BioPharma Cold Chain Packaging Market Size Forecast by Applications
12.10.1 Blood Components
12.10.2 Vaccines
12.10.3 Tissues
12.10.4 Cells
12.10.5 Stem Cells
12.10.6 Infectious Substances
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) BioPharma Cold Chain Packaging Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) BioPharma Cold Chain Packaging Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) BioPharma Cold Chain Packaging Market Size Forecast by Type
13.6.1 Metal Packaging
13.6.2 Glass Packaging
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) BioPharma Cold Chain Packaging Market Size Forecast by Applications
13.10.1 Blood Components
13.10.2 Vaccines
13.10.3 Tissues
13.10.4 Cells
13.10.5 Stem Cells
13.10.6 Infectious Substances
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 BioPharma Cold Chain Packaging Market: Competitive Dashboard
14.2 Global BioPharma Cold Chain Packaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amcor
14.3.2 CCL
14.3.3 Clondalkin
14.3.4 Gerresheimer
